"Estrogen Therapy" trang 1 - tải miễn phí từ tailieunhanh
Estrogen receptor alpha/beta ratio and estrogen receptor beta as predictors of endocrine therapy responsiveness–a randomized neoadjuvant trial comparison between anastrozole and tamoxifen for the treatment of postmenopausal breast cancer

Estrogen receptor alpha/beta ratio and estrogen receptor beta as predictors of endocrine therapy responsiveness–a randomized neoadjuvant trial comparison between anastrozole and tamoxifen for the treatment of postmenopausal breast cancer
12    95    1
Androgen receptor in advanced breast cancer: Is it useful to predict the efficacy of anti-estrogen therapy

Androgen receptor in advanced breast cancer: Is it useful to predict the efficacy of anti-estrogen therapy
8    63    1
Estrogen Therapy and Coronary-Artery Calcification

Estrogen Therapy and Coronary-Artery Calcification
13    51    0
Genome-independent hypoxic repression of estrogen receptor alpha in breast cancer cells

Genome-independent hypoxic repression of estrogen receptor alpha in breast cancer cells
16    84    1
Estrogen receptor beta expression in triple negative breast cancers is not associated with recurrence or survival

Estrogen receptor beta expression in triple negative breast cancers is not associated with recurrence or survival
12    4    1
Calcitriol restores antiestrogen responsiveness in estrogen receptor negative breast cancer cells: A potential new therapeutic approach

Calcitriol restores antiestrogen responsiveness in estrogen receptor negative breast cancer cells: A potential new therapeutic approach
10    43    1
ESR1 gene promoter region methylation in free circulating DNA and its correlation with estrogen receptor protein expression in tumor tissue in breast cancer patients

ESR1 gene promoter region methylation in free circulating DNA and its correlation with estrogen receptor protein expression in tumor tissue in breast cancer patients
8    37    1
Phase II randomized trial of neoadjuvant metformin plus letrozole versus placebo plus letrozole for estrogen receptor positive postmenopausal breast cancer (METEOR)

Phase II randomized trial of neoadjuvant metformin plus letrozole versus placebo plus letrozole for estrogen receptor positive postmenopausal breast cancer (METEOR)
5    56    1
Metformin enhances tamoxifen-mediated tumor growth inhibition in ER-positive breast carcinoma

Metformin enhances tamoxifen-mediated tumor growth inhibition in ER-positive breast carcinoma
11    30    1
The prevalence of estrogen receptor-negative breast cancer in Ethiopia

The prevalence of estrogen receptor-negative breast cancer in Ethiopia
6    28    1
Candidate methylation sites associated with endocrine therapy resistance in ER+/ HER2- breast cancer

Candidate methylation sites associated with endocrine therapy resistance in ER+/ HER2- breast cancer
15    34    1
FKBPL and its peptide derivatives inhibit endocrine therapy resistant cancer stem cells and breast cancer metastasis by downregulating DLL4 and Notch4

FKBPL and its peptide derivatives inhibit endocrine therapy resistant cancer stem cells and breast cancer metastasis by downregulating DLL4 and Notch4
14    45    1
Toremifene, a selective estrogen receptor modulator, significantly improved biochemical recurrence in bone metastatic prostate cancer: A randomized controlled phase II a trial

Toremifene, a selective estrogen receptor modulator, significantly improved biochemical recurrence in bone metastatic prostate cancer: A randomized controlled phase II a trial
8    55    1
Evaluating urinary estrogen and progesterone metabolites using dried filter paper samples and gas chromatography with tandem mass spectrometry (GC–MS/MS)

Evaluating urinary estrogen and progesterone metabolites using dried filter paper samples and gas chromatography with tandem mass spectrometry (GC–MS/MS)
12    71    0
Impact of molecular subtypes on the prediction of distant recurrence in estrogen receptor (ER) positive, human epidermal growth factor receptor 2 (HER2) negative breast cancer upon five years of endocrine therapy

Impact of molecular subtypes on the prediction of distant recurrence in estrogen receptor (ER) positive, human epidermal growth factor receptor 2 (HER2) negative breast cancer upon five years of endocrine therapy
9    90    0
C-Cbl reverses HER2-mediated tamoxifen resistance in human breast cancer cells

C-Cbl reverses HER2-mediated tamoxifen resistance in human breast cancer cells
13    76    1
LGR5 in breast cancer and ductal carcinoma in situ: A diagnostic and prognostic biomarker and a therapeutic target

LGR5 in breast cancer and ductal carcinoma in situ: A diagnostic and prognostic biomarker and a therapeutic target
14    22    1
Breast cancer primary tumor ER expression pattern predicts its expression concordance in matched synchronous lymph node metastases

Breast cancer primary tumor ER expression pattern predicts its expression concordance in matched synchronous lymph node metastases
7    38    1
Prognostic value of protein inhibitor of activated STAT3 in breast cancer patients receiving hormone therapy

Prognostic value of protein inhibitor of activated STAT3 in breast cancer patients receiving hormone therapy
7    69    1
Identification of stromal ColXα1 and tumor-infiltrating lymphocytes as putative predictive markers of neoadjuvant therapy in estrogen receptor-positive/HER2-positive breast cancer

Identification of stromal ColXα1 and tumor-infiltrating lymphocytes as putative predictive markers of neoadjuvant therapy in estrogen receptor-positive/HER2-positive breast cancer
13    62    1